GOAL.MD vs Vaylen
GOAL.MD and Vaylen both sell semaglutide and tirzepatide; this is how their prices, coverage and records differ.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Vaylen
Best for: bloodwork inside the $179/month rather than billed on top
Visit Vaylen →If you are choosing between GOAL.MD and Vaylen, price alone will not settle it. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Vaylen leads our six-part score, 8.2 to 7.8.
GOAL.MD vs Vaylen price
GOAL.MD and Vaylen start at the same figure, $179 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.
Drug by drug: Semaglutide costs the same at both, $179 a month; tirzepatide is cheaper at Vaylen ($239 a month vs $249 a month).
Medications and formats
Both sell semaglutide and tirzepatide.
On format they match: each offers compounded injections and brand-name pens.
Where each one treats patients
GOAL.MD lists 50 states, and Vaylen lists 50 states.
They overlap in 50 states.
Pricing
GOAL.MD
Personalized (compounded) tirzepatide from $249/mo new-patient first month; brand Zepbound from $394/mo
Vaylen
What each price covers
Both prices cover the clinician visit, the medication itself, shipping and coaching.
Vaylen's price also covers lab work, which GOAL.MD does not claim.
GOAL.MD is silent on lab work.
GOAL.MD
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
In the price
Vaylen
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
In the price
Coaching
In the price
Where each one scores higher
Overall, Vaylen scores 8.2 and GOAL.MD 7.8 out of 10.
GOAL.MD is stronger on user experience (8.0 vs 7.5).
Vaylen is stronger on trust & safety (8.5 vs 6.5) and support (10.0 vs 8.5).
Value, effectiveness and accessibility are within half a point.
GOAL.MD
7.8/10
Vaylen
8.2/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither GOAL.MD nor Vaylen has an FDA warning letter on record with us.
Features & Coverage
| Feature | GOAL.MD | Vaylen |
|---|---|---|
| Starting Price | $179/mo | $179/mo |
| Features | 8 features | 8 features |
| States Available | 50 | 50 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About GOAL.MD
GOAL.MD is a St. Louis-based telehealth platform. Compounded semaglutide starts at $179/mo, brand Ozempic and Wegovy from $294/mo, and Zepbound from $394/mo, with brand pen pricing published by dose tier and offered as a bridge to the brand drugs. Renewals are manual with no auto-billing, and a nutrition coach is included free.
Read our full GOAL.MD review →About Vaylen
Vaylen is a pure GLP-1 specialist: compounded semaglutide at $179/mo, compounded tirzepatide at $239/mo, a compounded oral GLP-1 at $259/mo, and brand-name Ozempic, Zepbound, and Wegovy. LegitScript certified, with licensed clinicians in all 50 states.
Read our full Vaylen review →Pros & Cons
GOAL.MD
What we like
- Semaglutide costs $179 a month, close to the $184 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $394 a month, 68% below the $1249 median for brand-name tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- The monthly price includes the medication, clinician visits, shipping and coaching
- Serves all 50 states
- We found no FDA warning letters issued to GOAL.MD
Watch-outs
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Vaylen
What we like
- Semaglutide costs $179 a month, close to the $184 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $239 a month, close to the $250 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits, shipping, lab work and coaching
- Serves all 50 states
- We found no FDA warning letters issued to Vaylen
- Baseline bloodwork is required before a prescription
Watch-outs
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Vaylen wins this one, 8.2 to 7.8, above all for bloodwork inside the $179/month rather than billed on top. GOAL.MD fits better if starting below a standard dose, with microdose tiers is your priority.
Choose GOAL.MD if…
You want starting below a standard dose, with microdose tiers and an opening price near $179 a month.
Choose Vaylen if…
You want bloodwork inside the $179/month rather than billed on top and an opening price near $179 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Willow
Seeing what it charges before you answer any medical questions
From $299/mo
Get started →Sesame Care
Oral orforglipron alongside the injectables
From $59/mo
Get started →Collective
Flat any-dose pricing, if you can absorb a $199 annual membership on top
From $59/mo
Get started →GOAL.MD vs Vaylen: FAQ
Close alternatives to GOAL.MD and Vaylen
- GOAL.MD vs TrimRx
- GOAL.MD vs DudeMeds
- GOAL.MD vs Healthicare
- Vaylen vs TrimRx
- Vaylen vs DudeMeds
- Vaylen vs Healthicare
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.